Cargando…
Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities()
Autores principales: | Portaluri, M., Barba, M.C., Musio, D., Tramacere, F., Pati, F., Bambace, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329675/ https://www.ncbi.nlm.nih.gov/pubmed/32621832 http://dx.doi.org/10.1016/j.radonc.2020.06.036 |
Ejemplares similares
-
Staff and Patient Protection in Radiation Oncology Departments During Coronavirus Disease 2019 (COVID-19) Pandemic
por: Portaluri, Maurizio, et al.
Publicado: (2020) -
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2
por: Jereczek-Fossa, Barbara Alicja, et al.
Publicado: (2021) -
COVID-19, radiotherapy and cancer()
por: Sriwijitalai, Won, et al.
Publicado: (2020) -
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)()
por: Jereczek-Fossa, Barbara Alicja, et al.
Publicado: (2020) -
Radiotherapy for COVID-19: Primum non nocere()
por: Boon, Ian S., et al.
Publicado: (2020)